Explanation
BACKGROUND: The Columbus Health Department, on behalf of the State Homeland Security Program, was awarded a grant from the Franklin County Office of Homeland Security and Justice for the acquisition of pharmaceuticals to strengthen current Columbus Metropolitan Medical Response System stocks of pharmaceuticals for emergency responders and add local capability for treating exposure to biological agents, nerve agents, and radiation until the strategic national stockpile arrives from the CDC in the event of bioterrorism activity in central Ohio. The Intergovernmental Agreements permit the City of Columbus and Franklin County to make these federal sub-grant expenditures and these agreements per Ordinance 1691-2006 passed 10/18/06. This ordinance authorizes the acceptance of the $300,000 grant from the Franklin County Office of Homeland Security and Justice and the purchase of pharmaceuticals from Akorn, Inc,; Heyltex Corp.; Meridian Medical Technologies; and Capital Wholesale in the amount of $260,588.92 for the period ending December 31, 2008.
Bid Information: Negotiated pricing was received from Akorn, Inc, Heyltex and Meridian Medical Technologies. Akorn, Inc. and Heyltex are sole manufacturers for the pharmaceuticals required to treat radiation exposure. Meridian is the sole manufacturer for pharmaceuticals required to treat convulsions due to nerve agent treatments. Due to the deadline of this grant, December 31, 2008, these purchases must be expedited and the City of Columbus, the Columbus Health Department is requesting that the pharmaceuticals be purchased from the sole source providers of the bioterrorism pharmaceuticals, Akorn, Inc.; Heyltex and Meridian Medical Technologies as follows:
Akorn, Inc. $96,525
Heyltex Corp $80,000
Meridian Medical
Technologies $ 6,552
SA002933 was publicized through Vendor Services on the City web site seeking bids for pha...
Click here for full text